SMTL ID : 1y5m.2 (1 other biounit)

The crystal structure of murine 11b-hydroxysteroid dehydrogenase: an important therapeutic target for diabetes

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-tetramer

Ligands

8 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 6 residues within 4Å: Chain A: K.28, G.29, R.32, T.204, E.205, K.222 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.29, A:E.205 Water bridges: A:T.206 Salt bridges: A:R.32, A:K.222 SO4.2: 1 residues within 4Å: Chain A: R.32 2 PLIP interactions: 2 interactions with chain A Water bridges: A:R.32 Salt bridges: A:R.32 SO4.5: 6 residues within 4Å: Chain B: K.28, G.29, R.32, T.204, E.205, K.222 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:G.29, B:E.205 Water bridges: B:R.32, B:T.206 Salt bridges: B:R.32, B:K.222 SO4.6: 2 residues within 4Å: Chain B: R.32, K.57 2 PLIP interactions: 2 interactions with chain B Salt bridges: B:R.32, B:K.57 SO4.9: 6 residues within 4Å: Chain C: K.28, G.29, R.32, T.204, E.205, K.222 6 PLIP interactions: 6 interactions with chain C Hydrogen bonds: C:G.29, C:E.205, C:E.205 Water bridges: C:T.206 Salt bridges: C:R.32, C:K.222 SO4.10: 1 residues within 4Å: Chain C: R.32 2 PLIP interactions: 2 interactions with chain C Water bridges: C:R.32 Salt bridges: C:R.32 SO4.13: 6 residues within 4Å: Chain D: K.28, G.29, R.32, T.204, E.205, K.222 6 PLIP interactions: 6 interactions with chain D Hydrogen bonds: D:G.29, D:E.205 Water bridges: D:R.32, D:T.206 Salt bridges: D:R.32, D:K.222 SO4.14: 2 residues within 4Å: Chain D: R.32, K.57 2 PLIP interactions: 2 interactions with chain D Salt bridges: D:R.32, D:K.57

4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.3: 30 residues within 4Å: Chain A: G.25, A.26, S.27, K.28, G.29, I.30, A.49, R.50, S.51, G.75, T.76, M.77, E.78, N.103, H.104, I.105, V.126, Y.131, I.152, S.153, S.154, Y.167, K.171, L.199, G.200, L.201, I.202, T.204, T.206, A.207 25 PLIP interactions: 25 interactions with chain A Hydrophobic interactions: A:L.199, A:I.202 Hydrogen bonds: A:G.25, A:S.27, A:S.27, A:K.28, A:I.30, A:R.50, A:R.50, A:R.50, A:S.51, A:M.77, A:I.105, A:Y.131, A:I.152, A:Y.167, A:K.171, A:K.171, A:I.202, A:T.204, A:T.204, A:T.206 Water bridges: A:G.31, A:N.103 Salt bridges: A:R.50 NDP.7: 30 residues within 4Å: Chain B: G.25, A.26, S.27, K.28, G.29, I.30, A.49, R.50, S.51, G.75, T.76, M.77, E.78, N.103, H.104, I.105, Y.131, I.152, S.153, S.154, Y.167, K.171, L.199, G.200, L.201, I.202, T.204, T.206, A.207 Ligands: OCT.8 24 PLIP interactions: 24 interactions with chain B Hydrophobic interactions: B:L.199, B:I.202 Hydrogen bonds: B:G.25, B:S.27, B:S.27, B:K.28, B:I.30, B:R.50, B:S.51, B:T.76, B:T.76, B:M.77, B:I.105, B:I.152, B:K.171, B:K.171, B:I.202, B:I.202, B:T.204, B:T.206 Water bridges: B:T.206 Salt bridges: B:K.28, B:K.28, B:R.50 NDP.11: 30 residues within 4Å: Chain C: G.25, A.26, S.27, K.28, G.29, I.30, A.49, R.50, S.51, G.75, T.76, M.77, E.78, N.103, H.104, I.105, V.126, Y.131, I.152, S.153, S.154, Y.167, K.171, L.199, G.200, L.201, I.202, T.204, T.206, A.207 26 PLIP interactions: 26 interactions with chain C Hydrophobic interactions: C:L.199, C:I.202 Hydrogen bonds: C:G.25, C:S.27, C:S.27, C:K.28, C:I.30, C:R.50, C:R.50, C:R.50, C:S.51, C:T.76, C:M.77, C:I.105, C:I.152, C:K.171, C:K.171, C:I.202, C:T.204 Water bridges: C:G.31, C:N.103, C:T.106, C:T.106, C:T.106, C:T.204 Salt bridges: C:R.50 NDP.15: 30 residues within 4Å: Chain D: G.25, A.26, S.27, K.28, G.29, I.30, A.49, R.50, S.51, G.75, T.76, M.77, E.78, N.103, H.104, I.105, Y.131, I.152, S.153, S.154, Y.167, K.171, L.199, G.200, L.201, I.202, T.204, T.206, A.207 Ligands: OCT.16 26 PLIP interactions: 26 interactions with chain D Hydrophobic interactions: D:L.199, D:I.202 Hydrogen bonds: D:G.25, D:S.27, D:S.27, D:K.28, D:I.30, D:R.50, D:S.51, D:T.76, D:M.77, D:I.105, D:Y.131, D:I.152, D:Y.167, D:K.171, D:K.171, D:I.202, D:I.202, D:T.204, D:T.204, D:T.206, D:T.206 Salt bridges: D:K.28, D:K.28, D:R.50

4 x OCT: N-OCTANE(Non-covalent)

OCT.4: 9 residues within 4Å: Chain A: L.155, Q.161, I.164, L.201, I.211, I.215, A.217 Chain B: S.264, Y.267 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:A.217 OCT.8: 10 residues within 4Å: Chain A: S.264, Y.267 Chain B: L.155, Q.161, I.164, L.201, I.211, I.215, A.217 Ligands: NDP.7 No protein-ligand interaction detected (PLIP) OCT.12: 9 residues within 4Å: Chain C: L.155, Q.161, I.164, L.201, I.211, I.215, A.217 Chain D: S.264, Y.267 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:A.217 OCT.16: 10 residues within 4Å: Chain C: S.264, Y.267 Chain D: L.155, Q.161, I.164, L.201, I.211, I.215, A.217 Ligands: NDP.15 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, J. et al., Crystal Structure of Murine 11-Hydroxysteroid Dehydrogenase 1: An Important Therapeutic Target for Diabetes. Biochemistry (2005)

Release Date

2005-05-17

Peptides

Corticosteroid 11-beta-dehydrogenase, isozyme 1: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Corticosteroid 11-beta-dehydrogenase, isozyme 1

Related Entries With Identical Sequence